News Release

Paclitaxel-coated balloon vs uncoated balloon for coronary in-stent restenosis


Peer-Reviewed Publication

JAMA Network

About The Study: Among patients undergoing coronary angioplasty for in-stent restenosis, a paclitaxel-coated balloon was superior to an uncoated balloon with respect to the composite end point of target lesion failure in this multicenter randomized trial that included 600 patients. Paclitaxel-coated balloons are an effective treatment option for patients with coronary in-stent restenosis. 

Authors: Robert W. Yeh, M.D., M.Sc., of Beth Israel Deaconess Medical Center in Boston, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link


Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: This study is being released to coincide with presentation at Cardiovascular Research Technologies 2024.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.